The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity

This publication has 51 references indexed in Scilit:

• Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position −107, implicating the Sp1 transcription factor
  Biochemical Journal, 2003
• Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum
  Journal of Lipid Research, 2003
• Polymorphisms in the human paraoxonase (PON1) promoter
  Pharmacogenetics, 2001
• A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression
  Atherosclerosis, 2000
• Promoter Polymorphisms of Human Paraoxonase PON1 Gene and Serum Paraoxonase Activities and Concentrations
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin
  Nature Genetics, 1996
• Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations
  Biochemical Journal, 1994
• The molecular basis of the human serum paraoxonase activity polymorphism
  Nature Genetics, 1993
• High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors.
  Proceedings of the National Academy of Sciences, 1992
• Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
  Journal of Clinical Investigation, 1990